University of California Irvine
Laguna Beach, California, United States
Susan O’Brien, MD, is a Professor of Medicine at the University of California, Irvine Health in Irvine, CA. She earned her medical degree from and completed her residency in Internal Medicine at the University of Medicine and Dentistry of New Jersey (currently known as the Rutgers School of Biomedical and Health Sciences). She completed her fellowship at the MD Anderson Cancer Center in Houston, TX.
Dr. O’Brien has been the principal investigator for more than 60 funded clinical research protocols and has authored more than 900 articles in peer-reviewed journals, 30 invited articles, and numerous book chapters and abstracts. She is currently the hematology executive officer for SWOG (formerly known as the Southwest Oncology Group Executive Committee) and the hematology editor for Clinical Lymphoma, Myeloma and Leukemia. She serves on the Board of Directors of the CLL Society and is the Treasurer of the iwCLL. Year after year, she is ranked nationally at the top in her field by America’s Top Doctors, Super Doctors, and America’s Top Doctors for Cancer.
Session XIII: BTKi as a Target
Saturday, October 21, 2023
7:30 AM – 9:15 AM ET
Saturday, October 21, 2023
8:20 AM – 8:40 AM ET
Panel Discussion: BTKi: Compare and Contrast Efficacy and Toxicity and Post-Session Audience Survey
Saturday, October 21, 2023
9:00 AM – 9:15 AM ET